Skip to content

Clinical application of imaging technology in patients with weight loss

Clinical application of imaging technology in patients with weight loss: a multicenter prospective observational study

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100043822
Enrollment
Unknown
Registered
2021-03-04
Start date
2021-03-31
Completion date
Unknown
Last updated
2021-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

case series:Nil

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients who need enteral nutrition support and gastrointestinal surgery; 2. Patients aged 18-75 years old; 3. Patients with body mass index (BMI) greater than 27.5 kg / m2 (inclusive) on admission; 4. Patients with APACHE-II score <= 15; 5. The patients whose hospital stay is expected to be more than 7 days after operation; 6. The patients who signed the informed consent voluntarily completed the questionnaire survey and follow-up as required; When it is impossible to sign the informed consent and complete the questionnaire survey and follow-up, the legal representative or guardian can do it on his behalf.

Exclusion criteria

Exclusion criteria: 1. Patients with hemodynamic instability, gastrointestinal bleeding, postoperative acute pancreatitis, inflammatory bowel disease (Crohn's disease or ulcerative colitis), intestinal ischemia, persistent intestinal obstruction, intestinal paralysis, high flow intestinal fistula and failure to establish distal access and other contraindications of enteral nutrition; 2. Patients with infectious diarrhea; 3. Patients with bone marrow or organ transplantation; 4. There are other patients with leukopenia, neutropenia, hematological malignancies and HIV who are not suitable for this study; 5. Patients with renal insufficiency (EGFR < 60ml / min) or need dialysis treatment; 6. Patients with abnormal thyroid function; 7. The patient, legal representative or guardian refused to participate in the study; 8. Pregnant or lactating women; 9. Patients who are known to be allergic to any one of the ingredients in the study or control products, or those whose dietary fiber intake needs to be restricted according to the judgment of the researchers; 10. Galactosemia; 11. Patients with expected survival <= 10 days.

Design outcomes

Primary

MeasureTime frame
MRI value;

Countries

China

Contacts

Public ContactChen Yi

West China Hospital of Sichuan University

476050057@qq.com+86 18980600628

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026